Kurata, Atsuo <br/><br/>
Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells.  [electronic resource] 

 -  PloS one  2020 
 - e0232055 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0232055  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Albumins--analysis<br/>Animals<br/>Cell Line<br/>Creatinine--blood<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Gene Expression Regulation--drug effects<br/>Glomerulonephritis--drug therapy<br/>Heterocyclic Compounds, 4 or More Rings--administration & dosage<br/>Humans<br/>Intercellular Signaling Peptides and Proteins--genetics<br/>Kidney--drug effects<br/>Kidney Function Tests<br/>Kidney Tubules--cytology<br/>Mice<br/>Mice, Transgenic<br/>Molecular Structure<br/>Protein Kinase Inhibitors--administration & dosage<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Rats<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Transforming Growth Factor beta1--genetics<br/>Axl Receptor Tyrosine Kinase